BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7478404)

  • 21. Labeling of monoclonal antibodies with radionuclides.
    Bhargava KK; Acharya SA
    Semin Nucl Med; 1989 Jul; 19(3):187-201. PubMed ID: 2503873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
    Sosabowsky J; Melendez-Alafort L; Mather S
    Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparation of 125I-labelled tetraiodothyroxine, T4, for the analysis of total serum T4 (RIA)].
    Santos I; Patrício L; Rodrigues A
    Acta Med Port; 1984; 5(9-10):255-9. PubMed ID: 6524448
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of electroimmunoassay for the determination of the in vivo stability of labelled proteins.
    Jánoki GA; Körösi L
    Nucl Med Commun; 1988 May; 9(5):339-45. PubMed ID: 3412726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in the preparation of 125I-labeled polypeptides, up to 11 amino acids, as RIA-tracers].
    Schmidt HE
    Radiobiol Radiother (Berl); 1984; 25(3):481-7. PubMed ID: 6473749
    [No Abstract]   [Full Text] [Related]  

  • 26. Preparation of a 125I-labelled conjugate of pteroylglutamic acid and its use in a radio ligand assay of folate in blood.
    Walton L
    Med Lab Sci; 1981 Jul; 38(3):187-95. PubMed ID: 7334916
    [No Abstract]   [Full Text] [Related]  

  • 27. Biomedical applications of radioiodinated peptides.
    Oliveira MC; Correia JDG
    Eur J Med Chem; 2019 Oct; 179():56-77. PubMed ID: 31238251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iodine monochloride (IC1) iodination techniques.
    Contreras MA; Bale WF; Spar IL
    Methods Enzymol; 1983; 92():277-92. PubMed ID: 6855615
    [No Abstract]   [Full Text] [Related]  

  • 29. Kit for carrier-free 123 I-sodium iodide. 8.
    Lambrecht RM; Norton E; Wolf AP
    J Nucl Med; 1973 May; 14(5):269-73. PubMed ID: 4698325
    [No Abstract]   [Full Text] [Related]  

  • 30. Radiolabelled peptides and monoclonal antibodies for therapy decision making in inflammatory diseases.
    Malviya G; Signore A; Laganà B; Dierckx RA
    Curr Pharm Des; 2008; 14(24):2401-14. PubMed ID: 18781990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide hormone receptors.
    Heinrich G
    N Engl J Med; 1982 Jun; 306(22):1368. PubMed ID: 6280053
    [No Abstract]   [Full Text] [Related]  

  • 32. The potential of perturbed angular correlation of gamma rays as a tool for dynamic studies of peptides/proteins.
    Bauer R; Atke A; Danielsen E; Marcussen J; Olsen CE; Rehfeld J; Saermark T; Schneider D; Vilhardt H; Zeppezauer M
    Int J Rad Appl Instrum A; 1991; 42(11):1015-23. PubMed ID: 1667309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method of preparing sterile radiopharmaceuticals using indicators.
    Colombetti LG; Goodwin DA; Hinkley RL
    J Nucl Med; 1969 Oct; 10(10):633-6. PubMed ID: 5808844
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the use of labeled polypeptide hormones].
    Simionescu L
    Stud Cercet Endocrinol; 1970; 21(2):177-80. PubMed ID: 5455452
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-inflammatory applications in vivo of radiolabelled leucocytes: a review.
    McAfee JG
    Nucl Med Commun; 1988 Oct; 9(10):733-44. PubMed ID: 3062508
    [No Abstract]   [Full Text] [Related]  

  • 36. Peptide radiopharmaceuticals in nuclear medicine.
    Blok D; Feitsma RI; Vermeij P; Pauwels EJ
    Eur J Nucl Med; 1999 Nov; 26(11):1511-9. PubMed ID: 10552097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer imaging with radiolabelled antibodies and peptides.
    Britton KE; Granowska M
    Nucl Med Rev Cent East Eur; 2002; 5(2):89-92. PubMed ID: 14600864
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution from Medical Imaging to Visualized Medicine.
    Shi Y; Liu Z
    Adv Exp Med Biol; 2023; 1199():1-13. PubMed ID: 37460724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
    Wild D; Schmitt JS; Ginj M; Mäcke HR; Bernard BF; Krenning E; De Jong M; Wenger S; Reubi JC
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1338-47. PubMed ID: 12937948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution and elimination characteristics of 111In-DTPA-D-phe1-octreotide and 111In-DTPA-L-phe1-octreotide in rats.
    Laznickova A; Laznicek M; Trejtnar F; Melicharova L; Suzuki KH; Akizawa H; Arano Y; Yokoyama A
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):37-43. PubMed ID: 11996325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.